Studies on the CV system have reported that NADPH oxidases promote endothelial dysfunction, inflammation, cardiac hypertrophy, fibrosis, apoptosis, and remodeling in vessel walls and the heart32,33. The gene discussed is FMO5; the disease is endothelial dysfunction.